EDGAR Filing Documents for 0001193125-17-101784

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-17-101784

Filing Date

2017-03-29

Accepted

2017-03-29 16:33:24

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-3	d363422ds3.htm	S-3	318936
2	EX-4.3	d363422dex43.htm	EX-4.3	29920
3	EX-4.4	d363422dex44.htm	EX-4.4	258508
4	EX-5.1	d363422dex51.htm	EX-5.1	32842
5	EX-12.1	d363422dex121.htm	EX-12.1	14329
6	EX-23.1	d363422dex231.htm	EX-23.1	1574
7	EX-23.2	d363422dex232.htm	EX-23.2	1331
8	GRAPHIC	g363422image00222.jpg	GRAPHIC	7946
	Complete submission text file	0001193125-17-101784.txt		669862

Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139

Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075

KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)